Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Niloy Chakrabarti

Four Convicted in $600K Insider Trading Scheme — Don't Risk Your Savings

Haghighat shared confidential acquisition details with his stepdaughter and friends, leading to insider trading profits. (Credit: Image by kasto on Canva)

Former director of Chinook Therapeutics, Rouzbeh 'Ross' Haghighat, has been convicted alongside several others for misusing material non-public information related to a $3.2 billion merger with Novartis, which led to illicit profits exceeding $600,000.

A federal jury in New Jersey found four individuals guilty on charges of insider trading. The US Securities and Exchange Commission (SEC) also filed civil insider trading charges against Haghighat, his family members, and close friends in August, alleging they purchased securities ahead of the public announcement of the Chinook acquisition by Novartis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.